Search filters

CLM94, a novel cyclic amide with anti-VEGFR-2 and antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 25 January 2012
Author/s

author: Stefania Sartini  Romano Danesi  Greta Alì  Federico Da Settimo Passetti  Michele N Minuto  Teresa Di Desidero  Guido Bocci  Piero Berti  Poupak Fallahi  Leonardo Fioravanti  Silvia Martina Ferrari  Gabriella Fontanini  Simona Piaggi  Concettina La Motta  Francesco Paolo Miccoli 

Publication date January 25, 2012
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item